Koate, Koate-Dvi Purple Book BLA 101130

BLA number
101130
Proprietary names
Koate, Koate-Dvi
Proper names
Antihemophilic Factor (Human)
Applicant
Grifols Therapeutics LLC
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Koate, Koate-DviAntihemophilic Factor (Human)351(a)1,000IUFor InjectionIntravenousSingle-Dose VialRxLicensed1974-01-24
002Koate, Koate-DviAntihemophilic Factor (Human)351(a)250IUFor InjectionIntravenousSingle-Dose VialRxLicensed1974-01-24
003Koate, Koate-DviAntihemophilic Factor (Human)351(a)500IUFor InjectionIntravenousSingle-Dose VialRxLicensed1974-01-24

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2021-05-01U001Koate, Koate-Dvi351(a)RxGrifols Therapeutics LLC
2021-05-01U002Koate, Koate-Dvi351(a)RxGrifols Therapeutics LLC
2021-05-01U003Koate, Koate-Dvi351(a)RxGrifols Therapeutics LLC
2020-08-01R001Koate, Koate-Dvi351(a)RxGrifols Therapeutics LLC
2020-08-01R002Koate, Koate-Dvi351(a)RxGrifols Therapeutics LLC
2020-08-01R003Koate, Koate-Dvi351(a)RxGrifols Therapeutics LLC

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2020-08-01001Koate, Koate-Dvi351(a)RxLicensed1974-01-24
2020-08-01002Koate, Koate-Dvi351(a)RxLicensed1974-01-24
2020-08-01003Koate, Koate-Dvi351(a)RxLicensed1974-01-24